Ovid Therapeutics Inc. (OVID) Reports Q2 EPS of $0.12

Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q2 EPS of $0.12, versus ($0.18) reported last year. Revenue for the quarter came in at $169 thousand, versus $75 thousand reported last year.

For earnings history and earnings-related data on Ovid Therapeutics Inc. (OVID) click here.

You May Also Be Interested In

• List of suppliers, parts, photos of iPhone 18 Pro are part of Tata Electronics data breach - Reuters
• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Copart (CPRT) 9200 contracts of December 27.50 calls trade, share price down 7.5%